Moderna Inc.

NASDAQ: MRNA · Real-Time Price · USD
28.00
1.31 (4.91%)
At close: Aug 15, 2025, 3:59 PM
28.06
0.20%
After-hours: Aug 15, 2025, 07:59 PM EDT

Moderna Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
1.93B 2.91B 3.21B 6.85B
Short-Term Investments
5.1B 5.7B 6.7B 3.88B
Long-Term Investments
2.51B 4.74B 8.36B 6.84B
Other Long-Term Assets
407M 523M 946M 46M
Receivables
592M 1.08B 1.69B 3.32B
Inventory
117M 202M 949M 1.44B
Other Current Assets
58M 88M 44M 26M
Total Current Assets
8.1B 10.32B 13.43B 16.07B
Property-Plant & Equipment
2.96B 2.66B 2.14B 1.38B
Goodwill & Intangibles
92M 96M n/a n/a
Total Long-Term Assets
6.04B 8.1B 12.43B 8.6B
Total Assets
14.14B 18.43B 25.86B 24.67B
Account Payables
405M 520M 487M 302M
Deferred Revenue
153M 568M 2.04B 6.25B
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
863M 842M 243M 140M
Total Current Liabilities
2.21B 3.02B 4.92B 9.13B
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
267M 256M 135M 76M
Total Long-Term Liabilities
1.03B 1.56B 1.81B 1.4B
Total Liabilities
3.24B 4.57B 6.74B 10.52B
Total Debt
747M 1.24B 1.2B 916M
Common Stock
n/a n/a n/a n/a
Retained Earnings
10.04B 13.61B 18.32B 9.96B
Comprehensive Income
-10M -123M -370M -24M
Shareholders Equity
10.9B 13.85B 19.12B 14.14B
Total Investments
7.61B 10.44B 15.06B 10.72B